Why the study?
Admission hyperglycemia often predicts poor clinical outcomes in non-diabetic AMI patients, but the appropriate cut-point to identify high-risk individuals remains controversial.
Does admission hyperglycemia predict in-hospital mortality in non-diabetic patients with acute myocardial infarction?
Comparison
Admission glucose levels: ≤140 mg/dL vs 141-179 mg/dL vs ≥180 mg/dL
Design
Retrospective observational study
Follow-up
In-hospital
Authors
Loading...
May flag higher in-hospital mortality risk via admission glucose in non-diabetic AMI; hypothesis-generating and needs prospective validation.
Does admission hyperglycemia predict in-hospital mortality in non-diabetic patients with acute myocardial infarction?
Severe admission hyperglycemia (≥180 mg/dL) is a strong independent predictor of in-hospital mortality in non-diabetic patients presenting with acute myocardial infarction.
Ding et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: